1 completed, 1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Non-Hodgkin T-cell Lymphoma: new trials by email Literature Review of Non-Hodgkin T-cell Lymphoma trials Research Report on Non-Hodgkin T-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SIMPLE Chemotherapy for NK Lymphoma/Leukaemia Cisplatin, Gemcitabine, Etoposide (VP-16) - Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin T-cell Lymphoma | Phase 3 | Unknown | The University of Hong Kong | 68 | 2017-07-01 | 2018-08-14 |
| Intercontinental Cooperative Non-Hodgkin T-cell Lymphoma Prospective Registry Study Prospective Registry - Non-Hodgkin T-cell Lymphoma | Completed | Samsung Medical Center | 500 | 2016-03-01 | 2020-09-09 |
Lymphoma, Non-Hodgkin (1) · Recurrence (1)
Disease Attributes (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Asparaginase (1) · Cisplatin (1) · Dexamethasone (1) · Etoposide (1) · Gemcitabine (1)
Samsung Medical Center (1) · The University of Hong Kong (1)
Hong Kong (1) · South Korea (1)